Schizophrenia Treatment Advances with Emerging Pipeline Insights Through 2024 [Yahoo! Finance]
Cyclerion Therapeutics, Inc. (CYCN)
Company Research
Source: Yahoo! Finance
This report confers a rich, panoramic view of over 70 companies and their 70+ pipeline drugs in the schizophrenia landscape, encompassing both clinical and nonclinical stage products. Delving into the depths of therapeutic assessment, the report meticulously classifies products by type, development stage, route of administration, and molecular archetype. It underscores the inactive pipeline projects as well, offering a holistic image of the current schizophrenia research space. Schizophrenia Overview: A Glimpse into the Disorder In its essence, schizophrenia is a chronic and severe mental disorder that affects an individual's interpretation of reality. Despite the absence of a definitive cause, the convergence of genetics, brain chemistry, and environmental factors is speculated to play critical roles in its onset. Symptoms range from hallucinations and delusions to cognitive impairments, necessitating a multifaceted approach to diagnosis and treatment. Emerging Therapeutic D
Show less
Read more
Impact Snapshot
Event Time:
CYCN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CYCN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CYCN alerts
High impacting Cyclerion Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
CYCN
Sec Filings
- 4/18/24 - Form 8-K
- 3/11/24 - Form 3
- 3/5/24 - Form 10-K
- CYCN's page on the SEC website